The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (pembro) in patients (pts) with sorafenib-treated (cohort 1) and treatment (tx)-naive (cohort 2) advanced hepatocellular carcinoma (aHCC) after additional follow-up in the phase 2 KEYNOTE-224 study.
 
Richard S. Finn
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; CStone Pharmaceuticals; Eisai; Exelixis; Genentech/Roche; Hengrui Therapeutics; Lilly; Medivir; Medivir; Merck; Pfizer
Speakers' Bureau - Genentech
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Masatoshi Kudo
Honoraria - AstraZeneca; Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
Consulting or Advisory Role - AstraZeneca; Chugai/Roche; Eisai; Roche
Research Funding - Abbvie (Inst); Chugai/Roche (Inst); Eisai (Inst); GE Healthcare (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)
 
Ivan Borbath
Honoraria - AstraZeneca; Eisai; Ipsen; Roche/Genentech (Inst); SERVIER (Inst)
Consulting or Advisory Role - Lilly (Inst)
Research Funding - SERVIER (Inst)
Travel, Accommodations, Expenses - Ipsen (Inst)
 
Julien Edeline
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Basilea; Bayer; BeiGene; Boston Scientific; Bristol-Myers Squibb; BTG; Eisai; Incyte; Ipsen; Merck Serono; MSD; Roche; SERVIER; Taiho Oncology
Research Funding - Beigene (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Exeliom Biosciences
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Stéphane Cattan
No Relationships to Disclose
 
Hans Van Vlierberghe
No Relationships to Disclose
 
Chris Verslype
Consulting or Advisory Role - Bayer; Ipsen; Roche; SERVIER
Speakers' Bureau - BAYER
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen; Servier
 
Daniel H. Palmer
Consulting or Advisory Role - Boston Scientific; Eisai; MSD; Roche
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Nucana; Sirtex Medical
 
Per Stål
Speakers' Bureau - Albireo Pharma; AstraZeneca; Eisai
Research Funding - Bristol-Myers Squibb; Intercept Pharmaceuticals; MSD
 
Sadahisa Ogasawara
Honoraria - AstraZeneca; Bayer; Chugai Pharma; Eisai; Lilly; MSD
Consulting or Advisory Role - AstraZeneca; Chugai Pharma
Research Funding - AstraZeneca; Bayer; Chugai Foundation for Innovative Drug Discovery Science; Eisai; Lilly
 
Arndt Vogel
Honoraria - Amgen; AstraZeneca/MedImmune; BeiGene; Boehringer Pharma GmbH; Boston Scientific; Bristol-Myers Squibb; Daichi-Sankyo; Eisai; GlaxoSmithKline; Incyte; Ipsen; Janssen; Lilly; MSD; Pierre Fabre; Roche; SERVIER; Sirtex Medical; Sirtex Medical; Taiho Oncology; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Boehringer Pharma GmbH; BTG; Daichi-Sankyo; EISAI; Incyte; IPSEN; Lilly; Novartis; Pierre Fabre; Roche; Sirtex Medical; Taiho Oncology; Taiho Oncology; Terumo
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Lilly; MSD; Roche
 
Mark Karwal
Consulting or Advisory Role - Eisai
Research Funding - Merck
 
Stephen Lam Chan
Honoraria - AstraZeneca; Eisai; MSD; Roche
Consulting or Advisory Role - AstraZeneca; BMS; Eisai; MSD Oncology; Roche
Research Funding - Eisai; MSD
Travel, Accommodations, Expenses - Ipsen; Roche
 
Jennifer J. Knox
Honoraria - AstraZeneca; Incyte; Ipsen; Roche Canada
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen; Lilly; Merck
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca; Incyte
 
Bruno Daniele
Honoraria - AstraZeneca; Eisai; Incyte; Roche
Consulting or Advisory Role - AstraZeneca; Eisai; Roche; Xenthera Inc.
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD
 
Amos Odeleye-Ajakaye
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Ken Hatogai
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Abby B. Siegel
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck
 
Ann-Lii Cheng
Honoraria - AstraZeneca; Bayer Yakuhin; Eisai; Genentech/Roche
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; BeiGene; Bristol-Myers Squibb; Eisai; Genentech/Roche; Ipsen; IQVIA; MSD; Omega Therapeutics, Inc.; Ono Pharmaceutical; Roche
 
Jean-Luc Van Laethem
No Relationships to Disclose